BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35061511)

  • 21. IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation.
    Pang X; Li X; Mo Z; Huang J; Deng H; Lei Z; Zheng X; Feng Z; Xie D; Gao Z
    BMC Gastroenterol; 2018 May; 18(1):61. PubMed ID: 29743020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.
    Shen C; Yan WZ; Zhao CY; Che HH; Liu XY; Liu ZZ; Wang YD; Wang W; Li M; Gao J
    J Microbiol Immunol Infect; 2015 Apr; 48(2):137-46. PubMed ID: 24388581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines.
    Sun Y; Chen HY; Xin SJ
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):230-4. PubMed ID: 15138116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF.
    Jia Y; Ma L; Wang Y; Wang W; Shen C; Wang X; Xu H; Zhao C
    Mol Immunol; 2020 Apr; 120():179-186. PubMed ID: 32169738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalance Between Soluble and Membrane-Bound CD100 Regulates Monocytes Activity in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure.
    Zhang DN; Liu Y; Li X; Gao Y; Xi FY; Li Y; Zhu GZ
    Viral Immunol; 2021 May; 34(4):273-283. PubMed ID: 33646067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloride intercellular channel 3 suppression-mediated macrophage polarization: a potential indicator of poor prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Liang J; Long Z; Zhang Y; Wang J; Chen X; Liu X; Gu Y; Zhang W; Zhang T; Chen Y; Zhang G; Sun W; Kuang D; Gao Z; Zheng Y
    Immunol Cell Biol; 2022 May; 100(5):323-337. PubMed ID: 35238065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of NLR versus MLR in the short-term prognostic assessment of HBV-related acute-on-chronic liver failure.
    Wang N; He S; Zheng Y; Wang L
    Int Immunopharmacol; 2023 Aug; 121():110489. PubMed ID: 37327515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between CD4+CD25+Treg cells, Th17 cells and IL-6 and the prognosis of hepatitis B virus-related acute-on-chronic liver failure: a meta-analysis].
    Lv H; Pan Z; Hu S; Chen Y; Zhuang Q; Yao X; Xu L; Xiao Z; Qiu L
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):493-8. PubMed ID: 25203799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated Serum IgG Levels Positively Correlated with IL-27 May Indicate Poor Outcome in Patients with HBV-Related Acute-On-Chronic Liver Failure.
    Zhang GL; Zhao QY; Xie C; Peng L; Zhang T; Gao ZL
    J Immunol Res; 2019; 2019():1538439. PubMed ID: 31198792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma.
    Liu S; Yang L; Jia S; Zhao R; Jin Z
    Int Immunopharmacol; 2021 Nov; 100():108161. PubMed ID: 34555643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
    Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
    Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DAMP molecular IL-33 augments monocytic inflammatory storm in hepatitis B-precipitated acute-on-chronic liver failure.
    Du XX; Shi Y; Yang Y; Yu Y; Lou HG; Lv FF; Chen Z; Yang Q
    Liver Int; 2018 Feb; 38(2):229-238. PubMed ID: 28640516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF.
    Li J; Liang X; Jiang J; Yang L; Xin J; Shi D; Lu Y; Li J; Ren K; Hassan HM; Zhang J; Chen P; Yao H; Li J; Wu T; Jin L; Ye P; Li T; Zhang H; Sun S; Guo B; Zhou X; Cai Q; Chen J; Xu X; Huang J; Hao S; He J; Xin S; Wang D; Trebicka J; Chen X; Li J;
    Gut; 2022 Jan; 71(1):163-175. PubMed ID: 33431576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
    Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
    Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-35 modulates the balance between viral specific CD4
    Yang L; Jia S; Shao X; Liu S; Zhang Q; Song J; Wang W; Jin Z
    Virol J; 2019 Apr; 16(1):48. PubMed ID: 30992023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoring the Treg cell to Th17 cell ratio may alleviate HBV-related acute-on-chronic liver failure.
    Niu YH; Yin DL; Liu HL; Yi RT; Yang YC; Xue HA; Chen TY; Zhang SL; Lin SM; Zhao YR
    World J Gastroenterol; 2013 Jul; 19(26):4146-54. PubMed ID: 23864777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocytic myeloid-derived suppressor cells increase infection risk
    Yu X; Sun J; Yang F; Mao R; Shen Z; Ren L; Yuan S; He Q; Zhang L; Yang Y; Ding X; He Y; Zhu H; Shen Z; Zhu M; Qiu C; Su Z; Zhang J
    Front Immunol; 2022; 13():966514. PubMed ID: 36685516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
    Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
    J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte Colony-Stimulating Factor Accelerates the Recovery of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure by Promoting M2-Like Transition of Monocytes.
    Tong J; Wang H; Xu X; Wan Z; Fang H; Chen J; Mu X; Liu Z; Chen J; Su H; Liu X; Li C; Huang X; Hu J
    Front Immunol; 2022; 13():885829. PubMed ID: 35651610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.